Article Information
History
- December 1, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Annalisa Tito1,*,
- Antonio Colantuono1,
- Luciano Pirone2,
- Emilia Pedone2,
- Daniela Intartaglia3,
- Giuliana Giamundo4,
- Ivan Conte3,5,
- Paola Vitaglione6 and
- Fabio Apone1,7
- 1Arterra Bioscience SPA, via Benedetto Brin 69, Naples, Italy
- 2Institute of Biostructures and Bioimaging, National Research Council, Via Mezzocannone 16, Naples, Italy
- 3Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, 80078 Pozzuoli (NA) Italy
- 4Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, via Pansini 5, Naples, Italy
- 5Department of Biology, University of Naples Federico II, via Cinthia, Naples, Italy
- 6Department of Agricultural science, University of Naples Federico II, via Università 100, Portici (NA), Italy
- 7Vitalab srl, via Benedetto Brin 69, Naples, Italy
- ↵* Corresponding author; email: annalisa{at}arterrabio.it
Posted December 01, 2020.
A pomegranate peel extract as inhibitor of SARS-CoV-2 Spike binding to human ACE2 (in vitro): a promising source of novel antiviral drugs
